Fairfield Financial Advisors, LTD Merck & Co., Inc. Transaction History
Fairfield Financial Advisors, LTD
- $284 Billion
- Q4 2024
A detailed history of Fairfield Financial Advisors, LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fairfield Financial Advisors, LTD holds 1,878 shares of MRK stock, worth $162,522. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,878
Previous 7,426
74.71%
Holding current value
$162,522
Previous $843 Million
77.85%
% of portfolio
0.07%
Previous 0.29%
Shares
11 transactions
Others Institutions Holding MRK
# of Institutions
3,887Shares Held
1.89BCall Options Held
15.7MPut Options Held
13.5M-
Vanguard Group Inc Valley Forge, PA251MShares$21.7 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.9 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$10.3 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$6.56 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.12 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $219B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...